Classification
CJC-1295 no DAC and Ipamorelin research blend
Classification organizes the research catalogue. It is not a claim of safety, efficacy, or approved use.
For Research Use Only · Not For Human or Veterinary Use · UK Research Compounds

Pre-combined GHRH-analog blend for research convenience.
Pre-combined GHRH-analog blend for research convenience.
CJC-1295 / Ipamorelin 20mg blend supplied for laboratory analytical research, independently tested for identity and mass.
EVLV fulfills research products from the United States and publishes product-specific batch documentation when a matching laboratory report is available. Testing methods and results are specific to the product and batch identified in each report.
This product is supplied in the format shown on this page: lyophilized powder.
For laboratory research use only. Not for human or veterinary use.
Compound research context
A dual-component label identifies the intended composition but does not verify an individual sample. The analytical record should name the blend, identify the sample, and provide appropriate results for both CJC-1295 no DAC and Ipamorelin.
Open the complete CJC/Ipamorelin research hubClassification
Classification organizes the research catalogue. It is not a claim of safety, efficacy, or approved use.
Analytical review
Confirm the listed strength and sample identifier, then evaluate CJC-1295 and Ipamorelin results separately. Also review the issuing laboratory, test date, and analytical methods stated in the report.
Available strengths
Product-specific questions
The listing identifies CJC-1295 no DAC and Ipamorelin as the two named research components.
Review the exact report for the methods and results stated for each analyte. Do not infer one component from the other.
Only when the report explicitly identifies the applicable product and sample. Each strength keeps a separate documentation status.